QualityStocksNewsBreaks Archives - Page 2 of 1520

MondayMar 23, 2026 12:55 pm

QualityStocksNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) HyBryte Data To Be Presented At USCLC Workshop Ahead Of AAD Meeting

Soligenix (NASDAQ: SNGX) announced that new supportive trial data for HyBryte(TM) in the treatment of cutaneous T-cell lymphoma will be presented at the United States Cutaneous Lymphoma Consortium Workshop on March 26, 2026, ahead of the American Academy of Dermatology Annual Meeting. The presentations will highlight positive results from a long-term treatment study and a comparative analysis versus Valchlor(R), supporting HyBryte(TM) potential as a therapeutic option for CTCL. To view the full press release, visit https://ibn.fm/W9RAl About Soligenix Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. Our Specialized BioTherapeutics business segment is developing and moving toward potential commercialization of HyBryte(TM) (SGX301…

MondayMar 23, 2026 12:39 pm

QualityStocksNewsBreaks – Nevada Organic Phosphate Inc. (CSE: NOP; OTCQB: NOPFF) Provides Update On Murdock Mountain Drilling Timeline

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising. Nevada Organic Phosphate (CSE: NOP; OTCQB: NOPFF) reported a delay in its planned drilling program at the Murdock Mountain phosphate project due to incomplete environmental pre-clearance surveys required by the Bureau of Land Management and Nevada Department of Wildlife, and has engaged an additional environmental consulting firm to accelerate completion of the work. The company is also finalizing an agreement with a second drilling contractor to mitigate scheduling impacts and enable drilling to commence as soon as regulatory approvals are secured. To view the full press release, visit https://ibn.fm/LGPsl Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) NOP is…

MondayMar 23, 2026 12:22 pm

QualityStocksNewsBreaks – McEwen Inc. (NYSE: MUX) (TSX: MUX) Reports Tartan Mine Resource Estimate With Over 600,000 Gold Ounces

This article has been disseminated on behalf of McEwen Inc. and may include paid advertising. McEwen (NYSE: MUX) (TSX: MUX) reported a mineral resource estimate for its Tartan Mine Project in Manitoba totaling 308,900 indicated gold ounces and 302,700 inferred gold ounces, with additional upside potential through further drilling across multiple zones and adjacent properties. The company said the project supports its goal of reaching 250,000 to 300,000 ounces of annual production by 2030, with initial output at Tartan expected to average approximately 30,000 ounces per year and potential expansion to 45,000 to 55,000 ounces annually through increased mill capacity, alongside ongoing exploration, metallurgical testing and mine planning initiatives. To view the full press release, visit, https://ibn.fm/KYiHz…

MondayMar 23, 2026 9:55 am

QualityStocksNewsBreaks – Planet Ventures Inc. (CSE: PXI) (OTC Pink: PNXPF) (FSE: P6U) Appoints Britt Tucker Strategic Advisor

This article has been disseminated on behalf of Planet Ventures Inc. and may include paid advertising. Planet Ventures (CSE: PXI) (OTC Pink: PNXPF) (FSE: P6U) announced the appointment of Britt Tucker as a strategic advisor, bringing experience in global sales, business development and partnerships across the commercial space sector. In her role, Tucker will support the company in identifying investment opportunities and strategic collaborations within the expanding space economy, leveraging her industry network and experience spanning human spaceflight, research platforms and emerging commercial ventures. To view the full press release, visit https://ibn.fm/Xhn9y About Planet Ventures Inc. Planet Ventures Inc. is…

MondayMar 23, 2026 9:40 am

QualityStocksNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Subsidiary Sapu Nano To Present Everolimus Toxicology Data At SOT 2026

Oncotelic Therapeutics (OTCQB: OTLC) announced that its subsidiary Sapu Nano will present new data on everolimus toxicology at the Society of Toxicology 2026 Annual Meeting and ToxExpo in San Diego, highlighting findings on tissue concentration–driven effects and organ-specific outcomes beyond traditional plasma pharmacokinetics. The presentation underscores the importance of tissue-level drug distribution in determining toxicity profiles and supports the development of improved delivery strategies, including intravenous and nanoparticle-based formulations. To view the full press release, visit https://ibn.fm/kZzE3 About Sapu Nano Sapu Nano is a biotechnology company developing next-generation nanomedicine platforms to improve drug delivery, enhance therapeutic index, and unlock new clinical…

MondayMar 23, 2026 9:30 am

QualityStocksNewsBreaks – DitGold (CRYPTO: DITAU) Listed On Coinranking Expands Visibility Across Independent Crypto Data Platform

DitGold (CRYPTO: DITAU) is now listed on Coinranking, an independent cryptocurrency data platform known for its real-time pricing, exchange aggregation and user-focused design, providing increased visibility and access to market data across more than 300 exchanges. Coinranking emphasizes unbiased listings without paid placement, alongside fast, mobile-first functionality and millisecond-level data updates, positioning DitAu within a transparent market data environment as the project continues to build out its blockchain-based ecosystem focused on the tokenization and monetization of data assets. About DitGold DitGold is a blockchain-based project built on the Ethereum network that seeks to position data as a core economic asset…

MondayMar 23, 2026 9:25 am

QualityStocksNewsBreaks – Linkers Industries Limited (NASDAQ: LNKS) Prices $16 Million Best Efforts Public Offering

Linkers Industries Limited (NASDAQ: LNKS) announced the pricing of a best-efforts public offering expected to generate approximately $16 million in gross proceeds through the sale of 23,088,023 units priced at $0.693 per unit, each consisting of one Class A ordinary share (or pre-funded warrant) and accompanying Series A and Series B warrants. The company said proceeds will be used in part to support a potential increase in its equity stake in LPW Electronics Co. Ltd., where it currently holds 20%, with the balance allocated to capital expenditures, working capital and general corporate purposes, with closing expected on or about March…

MondayMar 23, 2026 9:10 am

QualityStocksNewsBreaks – American Fusion Inc. (OTC: AMFN) Appoints Michael Carlson Chief Financial Officer

American Fusion (OTC: AMFN) announced the appointment of Michael Carlson as chief financial officer, bringing more than 30 years of experience in corporate finance, capital markets and advisory leadership, including prior roles at Budapest Airport and KPMG, as the company continues building its executive team to support capital formation and commercialization of its fusion energy platform. The company also reported completion of PCAOB audits for fiscal 2024 and 2025 and the filing of a Form 10 registration statement, while noting progress in ongoing legal matters, including a Delaware court decision denying motions related to its Series 2020 preferred shares and…

FridayMar 20, 2026 1:47 pm

QualityStocksNewsBreaks – DitGold (CRYPTO: DITAU) Gains Exposure as Coinbase Global Inc. (NASDAQ: COIN) Expands DEX Trading Access

DitGold (CRYPTO: DITAU) is now accessible through the Coinbase app decentralized exchange (DEX) functionality, enabling users to trade the token directly using assets such as USDC or ETH within the platform. The availability follows Coinbase Global Inc. (NASDAQ: COIN) continued expansion of its DEX capabilities, which provide access to a broad range of Ethereum- and Base-based tokens without requiring centralized exchange listings. The inclusion of DitAu within the Coinbase DEX ecosystem expands potential user access and liquidity while maintaining a decentralized trading structure, with transactions subject to network and platform fees. The token has not undergone Coinbase centralized listing review process, and the DEX feature remains available to…

FridayMar 20, 2026 1:17 pm

QualityStocksNewsBreaks – Co-Diagnostics, Inc. (NASDAQ: CODX) Expands CoSara Distribution Territory Across South Asia

Co-Diagnostics (NASDAQ: CODX) announced that its Indian joint venture, CoSara Diagnostics Pvt. Ltd., has signed an agreement to expand its commercial and distribution territory across South Asia to include Bangladesh, Pakistan, Nepal and Sri Lanka, significantly increasing its addressable market to an estimated $13.0 billion. The expansion supports planned commercialization of the CoSara PCR Pro(R) point-of-care platform and SARAGENE(R) product line, subject to regulatory approvals, as the company builds regional distribution channels and positions for broader deployment of its molecular diagnostics solutions. To view the full press release, visit https://ibn.fm/RkW6T About Co-Diagnostics, Inc. Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies. The Company's technologies…

Site Search

Company Search

Category: QualityStocksNewsBreaks